Liver injury model induced in mice by a cellular immunologic mechanism - study for use in immunopharmacological evaluations

Pharmacological Research

Volumn 35, Issue 4, 1997, Pages 273-278

  Xu, Qiang ^a,b   Lu, Jinfu ^a   Wang, Rong ^a   Wu, Feihua ^a   Cao, Jingsong ^a   Chen, Xiaochun ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Delayed type hypersensitivity; Liver injury; Pharmacological evaluation; Picryl chloride

Indexed keywords

AMINOTRANSFERASE; ANTIINFLAMMATORY AGENT; CYCLOPHOSPHAMIDE; DICARBOXYLIC ACID DERIVATIVE; GLYCYRRHIZIC ACID; IMMUNOSUPPRESSIVE AGENT; KRESTIN; MALOTILATE; PICRYL CHLORIDE; PREDNISOLONE;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; DELAYED HYPERSENSITIVITY; FEMALE; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IMMUNOPHARMACOLOGY; LIVER INJURY; LIVER PROTECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031126785     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1997.0164     Document Type: Article

References (26)

1. Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis. Ann Rev Immunol. 13:1995;29-60.
2. Mondelli M, Vergani GM, Alberti A, Vergani D, Portmann B, Eddleston ALWF, Williams R. Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes. J Immunol. 129:1982;2773-2778.
3. Barnaba V, Franco A, Alberti A, Balsano C, Benvenuto R, Balsano F. Recognition of hepatitis B virus envelope proteins by liver-infiltrating T lymphocytes in chronic HBV infection. J Immunol. 143:1989;2650-2655.
4. Ferrari C, Penna A, Giuberti T, Tong MJ, Ribera E, Fiaccadori F, Chisari FV. Introhepatic, nucleocapsid antigen-specific T cells in chronic active hepatitis B. J Immunol. 139:1987;2050-2058.
5. Moriyama T, Guilhot S, Klopchin K, Moss B, Pinkert CA, Palmiter RD, Brinster RL, Kanagawa O, Chisari FV. Immunobiology and pathogenesis of hepatocellular injury in hepatitis B transgenic mice. Science. 248:1990;361-364.
6. Peters M, Vierling J, Gershwin ME, Milich D, Chisari FV, Hoofnagle JH. Immunology and the liver. Hepatology. 13:1991;977-994.
7. +. Liver. 16:1996;174-182.
8. Napoli J, Bishop GA, McGuinness PH, Painter DM, McCaughan GW. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology. 24:1996;759-765.
9. +. J Exp Med. 178:1993;17-25.
10. Botaelli P, Brunetto MR, Minutello MA, Calvo P, Unutmaz D, Weiner AJ, Choo Q-L, Shuster JR, Kuo G, Bonino F, Houghton M, Abrignani S. T-lymphocyte response to hepatitis C virus in different clinical courses of infection. Gastroenterology. 104:1993;580-587.
11. Xu Q, Wang R, Xu L. Animal model of the liver injury induced by a mechanism of delayed type hypersensitivity. Chin J Immunol. 9:1993;287-290.
12. Xu Q, Wang R, Jiang J, Wu F, Lu J, Tan PK, Xu L. Liver injury model in mice induced by a cellular immunologic mechanism - delayed-type hypersensitivity-induced liver injury to picryl chloride and phenotype of effector cell. Cell Immunol. 167:1996;38-43.
13. Xu Q, Wu F, Zhang B, Jiang J, Lu J, Cao J, Wang R, Feng Z. One-shot delayed-type hypersensitivity reaction in the mouse liver causes a sustained liver injury to picryl chloride. Life Sci. 60:1997;2417-2425.
14. Liu G, Wang G, Wei H, Bao T, Song Z. A comparison of the protective actions of biphenyl dimethyl-dicarboxylate, trans-stilbene, alcoholic extracts of Fructus schizandrae and Ganoderma against experimental liver injury in mice. Acta Pharmaceutica Sinica. 14:1979;598-604.
15. Liu G. Therapeutic effects of biphenyl dimethyl dicarboxylate (DDB) on chronic viral hepatitis B. Proc Chin Acad Med Sci Beijing Union Med Coll. 2:1987;228-233.
16. Fu T, Liu G. Protective effects of dimethyl-4, 4′-dimethoxy-5, 6, 5′, 6′-dimethylene dioxybiphenyl-2, 2′-dicarboxylate on damages of isolated rat hepatocytes induced by carbon tetrachloride andD. Biomed Environ Sci. 5:1992;185-194.
17. Davila JC, Lenherr A, Acosta D. Protective effect of flavonoids on drug-induced hepatotoxicityin vitro. Toxicology. 57:1989;267-286.
18. Pietrangelo A, Borella F, Casalgrandi G, Montosi G, Ceccarelli D, Gallesi D, Giovannini F, Gasparetto A, Masini A. Antioxidant activity of silybinin vivo. Gastroenterology. 109:1995;1941-1949.
19. Mitsuoka A, Morikawa S, Baba M, Harada T. Cyclophosphamide eliminates suppressor T cells in aged-associated central regulation of delayed hypersensitivity in mice. J Exp Med. 149:1979;1018-1028.
20. Xu Q, Zhao H, Hang B. Inhibition of delayed type hypersensitivity reaction byFructus Tribuli. J China Pharmaceut Univ. 22:1991;12-16.
21. Xu Q, Wang R, Jiang J. Effects ofRhizoma smilacis glabrae. Chin J Immunol. 9:1993;39-42.
22. Segal HL, Rosso RG, Hopper S, Weber MM. Direct evidence for an increase in enzyme level as the basis for the glucocorticoid-induced increase in glutamic-alanine transaminase activity in rat liver. J Biol Chem. 237:1962;PC3303-PC3305.
23. Segal HL, Kim YS. Glucocorticoid stimulation of the biosynthesis of glutamic-alanine transaminase. Proc Nat Acad Sci. 50:1963;912-918.
24. Fittschen C, Bellamy JEC. Prednisolone-induced morphologic and chemical changes in the liver of dogs. Vet Pathol. 21:1984;399-406.
25. Abe Y, Ueda T, Kato T, Kohli Y. Effectiveness of interferon, glycyrrhzin combination therapy in patients with chronic hepatitis. Jap J Clin Med. 52:1994;1817-1822.
26. Sandgren EP, Palmiter RD, Heckel JL, Daygherty CC, Brinster RL, Degen JL. Complete hepatic regeneration after somatic deletion of an albumin-plasminogen activator transgene. Cell. 66:1991;245-256.